Disclosure of HIV status and associated clinical outcomes of children and adolescents living with HIV in Asia.
Saved in:
| Title: | Disclosure of HIV status and associated clinical outcomes of children and adolescents living with HIV in Asia. |
|---|---|
| Authors: | Sornillo, Johanna Beulah, Ditangco, Rossana, Lumbiganon, Pagakrong, Vu, Thien An, Le, Oanh Ngoc, Truong, Khanh Huu, Nguyen, Lam Van, Do, Viet Chau, Ounchanum, Pradthana, Wati, Dewi Kumara, Puthanakit, Thanyawee, Kurniati, Nia, Lapphra, Keswadee, Sudjaritruk, Tavitiya, Kumarasamy, Nagalingeswaran, Jamal Mohamed, Thahira A, Nik Yusoff, Nik Khairulddin, Fong, Siew Moy, Nallusamy, Revathy A., Sohn, Annette H. |
| Source: | AIDS Care. Dec2023, Vol. 35 Issue 12, p1928-1937. 10p. |
| Subjects: | Mortality prevention, HIV infection prognosis, HIV infections, Disclosure, Evaluation of medical care, Disease progression, Patient aftercare, Combination drug therapy, Antiretroviral agents, Patient compliance, Psychology of HIV-positive persons, Longitudinal method, Proportional hazards models, Child mortality, Therapeutics, Children, Adolescence |
| Geographic Terms: | Asia |
| Abstract: | Disclosure of HIV status is an important part of pediatric care. We studied disclosure and clinical outcomes in a multi-country Asian cohort of children and adolescents with HIV. Those 6–19 years of age who initiated combination antiretroviral therapy (cART) between 2008 and 2018, and who had at least one follow-up clinic visit were included. Data up to December 2019 were analyzed. Cox and competing risk regression analyses were used to assess the effect of disclosure on disease progression (WHO clinical stage 3 or 4), loss to follow-up (LTFU; > 12 months), and death. Of 1913 children and adolescents (48% female; median [IQR] age 11.5 [9.2–14.7] years at last clinic visit), 795 (42%) were disclosed to about their HIV status at a median age of 12.9 years (IQR: 11.8–14.1). During follow-up, 207 (11%) experienced disease progression, 75 (3.9%) were LTFU, and 59 (3.1%) died. There were lower hazards of disease progression (adjusted hazard ratio [aHR] 0.43 [0.28–0.66]) and death (aHR 0.36 [0.17–0.79]) for those disclosed to compared with those who were not. Disclosure and its appropriate implementation should be promoted in pediatric HIV clinics in resource-limited settings. [ABSTRACT FROM AUTHOR] |
| Copyright of AIDS Care is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 173451956 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Disclosure of HIV status and associated clinical outcomes of children and adolescents living with HIV in Asia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Sornillo%2C+Johanna+Beulah%22">Sornillo, Johanna Beulah</searchLink><br /><searchLink fieldCode="AR" term="%22Ditangco%2C+Rossana%22">Ditangco, Rossana</searchLink><br /><searchLink fieldCode="AR" term="%22Lumbiganon%2C+Pagakrong%22">Lumbiganon, Pagakrong</searchLink><br /><searchLink fieldCode="AR" term="%22Vu%2C+Thien+An%22">Vu, Thien An</searchLink><br /><searchLink fieldCode="AR" term="%22Le%2C+Oanh+Ngoc%22">Le, Oanh Ngoc</searchLink><br /><searchLink fieldCode="AR" term="%22Truong%2C+Khanh+Huu%22">Truong, Khanh Huu</searchLink><br /><searchLink fieldCode="AR" term="%22Nguyen%2C+Lam+Van%22">Nguyen, Lam Van</searchLink><br /><searchLink fieldCode="AR" term="%22Do%2C+Viet+Chau%22">Do, Viet Chau</searchLink><br /><searchLink fieldCode="AR" term="%22Ounchanum%2C+Pradthana%22">Ounchanum, Pradthana</searchLink><br /><searchLink fieldCode="AR" term="%22Wati%2C+Dewi+Kumara%22">Wati, Dewi Kumara</searchLink><br /><searchLink fieldCode="AR" term="%22Puthanakit%2C+Thanyawee%22">Puthanakit, Thanyawee</searchLink><br /><searchLink fieldCode="AR" term="%22Kurniati%2C+Nia%22">Kurniati, Nia</searchLink><br /><searchLink fieldCode="AR" term="%22Lapphra%2C+Keswadee%22">Lapphra, Keswadee</searchLink><br /><searchLink fieldCode="AR" term="%22Sudjaritruk%2C+Tavitiya%22">Sudjaritruk, Tavitiya</searchLink><br /><searchLink fieldCode="AR" term="%22Kumarasamy%2C+Nagalingeswaran%22">Kumarasamy, Nagalingeswaran</searchLink><br /><searchLink fieldCode="AR" term="%22Jamal+Mohamed%2C+Thahira+A%22">Jamal Mohamed, Thahira A</searchLink><br /><searchLink fieldCode="AR" term="%22Nik+Yusoff%2C+Nik+Khairulddin%22">Nik Yusoff, Nik Khairulddin</searchLink><br /><searchLink fieldCode="AR" term="%22Fong%2C+Siew+Moy%22">Fong, Siew Moy</searchLink><br /><searchLink fieldCode="AR" term="%22Nallusamy%2C+Revathy+A%2E%22">Nallusamy, Revathy A.</searchLink><br /><searchLink fieldCode="AR" term="%22Sohn%2C+Annette+H%2E%22">Sohn, Annette H.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22AIDS+Care%22">AIDS Care</searchLink>. Dec2023, Vol. 35 Issue 12, p1928-1937. 10p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Mortality+prevention%22">Mortality prevention</searchLink><br /><searchLink fieldCode="DE" term="%22HIV+infection+prognosis%22">HIV infection prognosis</searchLink><br /><searchLink fieldCode="DE" term="%22HIV+infections%22">HIV infections</searchLink><br /><searchLink fieldCode="DE" term="%22Disclosure%22">Disclosure</searchLink><br /><searchLink fieldCode="DE" term="%22Evaluation+of+medical+care%22">Evaluation of medical care</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+progression%22">Disease progression</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+aftercare%22">Patient aftercare</searchLink><br /><searchLink fieldCode="DE" term="%22Combination+drug+therapy%22">Combination drug therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Antiretroviral+agents%22">Antiretroviral agents</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+compliance%22">Patient compliance</searchLink><br /><searchLink fieldCode="DE" term="%22Psychology+of+HIV-positive+persons%22">Psychology of HIV-positive persons</searchLink><br /><searchLink fieldCode="DE" term="%22Longitudinal+method%22">Longitudinal method</searchLink><br /><searchLink fieldCode="DE" term="%22Proportional+hazards+models%22">Proportional hazards models</searchLink><br /><searchLink fieldCode="DE" term="%22Child+mortality%22">Child mortality</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink><br /><searchLink fieldCode="DE" term="%22Children%22">Children</searchLink><br /><searchLink fieldCode="DE" term="%22Adolescence%22">Adolescence</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Asia%22">Asia</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Disclosure of HIV status is an important part of pediatric care. We studied disclosure and clinical outcomes in a multi-country Asian cohort of children and adolescents with HIV. Those 6–19 years of age who initiated combination antiretroviral therapy (cART) between 2008 and 2018, and who had at least one follow-up clinic visit were included. Data up to December 2019 were analyzed. Cox and competing risk regression analyses were used to assess the effect of disclosure on disease progression (WHO clinical stage 3 or 4), loss to follow-up (LTFU; > 12 months), and death. Of 1913 children and adolescents (48% female; median [IQR] age 11.5 [9.2–14.7] years at last clinic visit), 795 (42%) were disclosed to about their HIV status at a median age of 12.9 years (IQR: 11.8–14.1). During follow-up, 207 (11%) experienced disease progression, 75 (3.9%) were LTFU, and 59 (3.1%) died. There were lower hazards of disease progression (adjusted hazard ratio [aHR] 0.43 [0.28–0.66]) and death (aHR 0.36 [0.17–0.79]) for those disclosed to compared with those who were not. Disclosure and its appropriate implementation should be promoted in pediatric HIV clinics in resource-limited settings. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of AIDS Care is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=173451956 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/09540121.2023.2176424 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1928 Subjects: – SubjectFull: Mortality prevention Type: general – SubjectFull: HIV infection prognosis Type: general – SubjectFull: HIV infections Type: general – SubjectFull: Disclosure Type: general – SubjectFull: Evaluation of medical care Type: general – SubjectFull: Disease progression Type: general – SubjectFull: Patient aftercare Type: general – SubjectFull: Combination drug therapy Type: general – SubjectFull: Antiretroviral agents Type: general – SubjectFull: Patient compliance Type: general – SubjectFull: Psychology of HIV-positive persons Type: general – SubjectFull: Longitudinal method Type: general – SubjectFull: Proportional hazards models Type: general – SubjectFull: Child mortality Type: general – SubjectFull: Therapeutics Type: general – SubjectFull: Children Type: general – SubjectFull: Adolescence Type: general – SubjectFull: Asia Type: general Titles: – TitleFull: Disclosure of HIV status and associated clinical outcomes of children and adolescents living with HIV in Asia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sornillo, Johanna Beulah – PersonEntity: Name: NameFull: Ditangco, Rossana – PersonEntity: Name: NameFull: Lumbiganon, Pagakrong – PersonEntity: Name: NameFull: Vu, Thien An – PersonEntity: Name: NameFull: Le, Oanh Ngoc – PersonEntity: Name: NameFull: Truong, Khanh Huu – PersonEntity: Name: NameFull: Nguyen, Lam Van – PersonEntity: Name: NameFull: Do, Viet Chau – PersonEntity: Name: NameFull: Ounchanum, Pradthana – PersonEntity: Name: NameFull: Wati, Dewi Kumara – PersonEntity: Name: NameFull: Puthanakit, Thanyawee – PersonEntity: Name: NameFull: Kurniati, Nia – PersonEntity: Name: NameFull: Lapphra, Keswadee – PersonEntity: Name: NameFull: Sudjaritruk, Tavitiya – PersonEntity: Name: NameFull: Kumarasamy, Nagalingeswaran – PersonEntity: Name: NameFull: Jamal Mohamed, Thahira A – PersonEntity: Name: NameFull: Nik Yusoff, Nik Khairulddin – PersonEntity: Name: NameFull: Fong, Siew Moy – PersonEntity: Name: NameFull: Nallusamy, Revathy A. – PersonEntity: Name: NameFull: Sohn, Annette H. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09540121 Numbering: – Type: volume Value: 35 – Type: issue Value: 12 Titles: – TitleFull: AIDS Care Type: main |
| ResultId | 1 |